Skip to main content

SV Health Investors — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

76
Companies
$1.9B
Total invested
$34.1M
Avg. check
33
Industries
Biotechnology 15Health Care 15Medical 9Therapeutics 5Life Science 4Medical Device 4+27 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 4972 of 76
Cerevance
April 2024

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

Biotechnology · Boston$47.0M Series B
Eyebiotech
November 2023

Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.

Biotechnology · New York$65.0M Series A
Vittoria Biotherapeutics
November 2023

Vittoria Biotherapeutics is a gene-edited cell therapeutics company.

Bioinformatics · Philadelphia$15.0M Series Unknown
Sitryx Therapeutics
September 2023

Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.

Biotechnology · Oxford$39.0M Series A
Pulmocide
December 2022

Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.

Biotechnology · London$52.0M Series C
Rondo Therapeutics
March 2022

Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.

Biopharma · Hayward$67.0M Series A
Caraway Therapeutics
November 2020

Rheostat Therapeutics is a bio therapeutics company.

Biotechnology · CambridgeGrant
AavantiBio
October 2020

AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.

Biotechnology · Cambridge$107.0M Series A
Stimwave Technologies
September 2020

Stimwave Technologies develops and markets wireless microsize injectable medical devices for neurology markets.

Hardware · Pompano Beach$796K Series Unknown
Pionyr Immunotherapeutics
June 2020

Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.

Biotechnology · South San Francisco$275.0M Corporate Round
CytoMed Therapeutics
January 2020

CytoMed Therapeutics is a cancer immunotherapy startup.

Biotechnology · SingaporeSeries Unknown
EBT Medical
November 2019

EBT Medical is a clinical-stage startup developing disruptive neuromodulation therapies for pelvic health disorders.

Health Care · Toronto$10.0M Series A
Healthify
November 2019

SaaS - There's more to health than healthcare.

Health Care · New York$16.0M Series B
Urgent Team Holdings, Inc.
October 2018

Urgent Team operates centers providing urgent and primary healthcare services and preventative wellness services.

Biotechnology · Nashville$18.0M Series D
Centauri Health Solutions
June 2018

A technology-centric company specializing in hosted software solutions, data-driven services, and data management.

Data Management · Scottsdale$18.2M Series Unknown
Schweiger Dermatology
May 2018

Schweiger Dermatology is a full service cosmetic & general dermatology.

Cosmetic Surgery · New York$100.0M Private Equity
Autifony Therapeutics
March 2017

Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.

Biotechnology · London$1.6M Series Unknown
Atopix Therapeutics
November 2016

Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK

Biotechnology · AbingdonSeries Unknown
Cibiem, Inc.
October 2016

Cibiem, a medical device company, develops minimally invasive, catheter-based therapeutics for sympathetic nervous system-mediated diseases.

Health Care · Los AltosDebt Financing
Nordic
October 2016

Nordic offers information technology advisement to companies in the healthcare industry.

Advice · MadisonPrivate Equity
Maestro Health
October 2016

Maestro Health offers a technology-meets-service platform that is reimagining employee benefits.

Employee Benefits · ChicagoSeries A
Kesios Therapeutics
August 2016

Kesios Therapeutics, a London, UK-based oncology drug discovery company

Biotechnology · LondonDebt Financing
Aligned TeleHealth
August 2016

Aligned Telehealth is a provider of a SaaS-based platform used to offer telemedicine and healthcare management services.

Health Care · Woodland Hills$11.9M Series A
TopiVert
April 2016

Imperial Innovations creates and invests in pioneering university technologies addressing healthcare, energy and environmental problems.

Angel Investment · LondonSeries A

Where SV Health Investors invests

Biotechnology15
Health Care15
Medical9
Therapeutics5
Life Science4
Medical Device4

About SV Health Investors's portfolio

How many companies has SV Health Investors invested in?

SV Health Investors has invested in 76 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does SV Health Investors invest in?

SV Health Investors's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 33 different industry categories.

What is SV Health Investors's largest investment?

Among tracked funding rounds, Pionyr Immunotherapeutics received $275.0M in a Corporate Round round. SV Health Investors's total known invested capital is $1.9B.

What is the average investment size for SV Health Investors?

SV Health Investors's average investment size is $34.1M across its portfolio of 76 companies.

What are SV Health Investors's most recent investments?

Recent SV Health Investors portfolio additions include Cerevance, Eyebiotech, Vittoria Biotherapeutics, Sitryx Therapeutics, Pulmocide. These companies were founded in 2020 or later.

Reach the founders behind these 76 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →